Study of ALXN1840 Versus Standard of Care in Pediatric Participants With Wilson Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Eugene S. Swenson, MD, PhD
Alexion Pharmaceuticals, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
20 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Parkville, Australia
- Research Site
South Brisbane, Australia
- Research Site
Lille, France
- Research Site
Toulouse, France
- Research Site
Hanover, Germany
- Research Site
Tübingen, Germany
- Research Site
Kumamoto, Japan
- Research Site
Kurume-shi, Japan
- Research Site
Meguro-ku, Japan
- Research Site
Sapporo, Japan
- Research Site
Warsaw, Poland
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Seoul, South Korea
- Research Site
Barcelona, Spain
- Research Site
Esplugues de Llobregat, Spain
- Research Site
Las Palmas de Gran Canaria, Spain
- Research Site
Madrid, Spain
- Research Site
Málaga, Spain
- Research Site
Pamplona, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Sept 2021
- Primary completion
- 26 Jun 2023
- Completion
- 26 Jun 2023
- Last update posted
- 23 Oct 2024
- Registered enrollment
- 40
- Registry id
- NCT05047523
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.